Efficacy and Safety of Antihypertensive Treatment With Mobile Stroke Units in Ultra-Early Intracerebral Hemorrhage

MSU-ICH is a prospective, multicenter, Week-wise-randomized, open-label, blinded-endpoint (PROBE) clinical trial comparing ultra-early prehospital blood pressure lowering delivered by a Mobile Stroke Unit (MSU) with standard Emergency Medical Services (EMS) in patients with spontaneous intracerebral hemorrhage.

NCT Number	NCT07665827
Lead Sponsor	Xuanwu Hospital, Beijing Collaborators: Beijing Emergency Medical Center, Huizhou Third People's Hospital, Guangzhou Medical University, Suzhou First People's Hospital, Nanyang Nanshi Hospital
Conditions	Nervous System Diseases, Cerebrovascular Disorders, Cardiovascular Diseases, Vascular Diseases, Hemorrhage, Intracranial Hemorrhages, Cerebral Hemorrhage, Cerebral Hemorrhage, Hypertensive +2 more
Enrollment	706 participants
Start Date	2026-06
Primary Completion	2028-04 (estimated)
Study Completion	2028-07 (estimated)
Updated on ClinicalTrials.gov	2026-06-24